Eduardo M. Acevedo‐Vásquez
Eduardo M. Acevedo‐Vásquez publishes mostly in Rheumatology, Genetics and Immunology, on topics such as Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies and Atherosclerosis and Cardiovascular Diseases.
- World rank
- #1,016,726 of 7,710,434 ranked researchers
- Rank in Peru
- #261 of 7,808
- Works
- 50
- Citations
- 2.3k
- Citations per work
- 45.1
What does Eduardo M. Acevedo‐Vásquez research?
Eduardo M. Acevedo‐Vásquez's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (8%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2549.1%
- Medicine2549.1%
- Everything else1836.5%
- Life Sciences714.4%
- 1Rheumatology35% of their works
- 2Genetics8% of their works
- 3Immunology6% of their works
- 4Public Health, Environmental and Occupational Health5% of their works
- 5Pathology and Forensic Medicine4% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Atherosclerosis and Cardiovascular Diseases
- Genetic Associations and Epidemiology
- Autoimmune and Inflammatory Disorders Research
- Tuberculosis Research and Epidemiology
- Spondyloarthritis Studies and Treatments
- Chronic Lymphocytic Leukemia Research
Which keywords describe Eduardo M. Acevedo‐Vásquez's research?
The keywords of their largest research topics: Autoantibodies, Antiphospholipid Syndrome, Cytokines, Inflammation, Systemic Lupus Erythematosus, Biological Therapy, Rheumatoid Arthritis and Immune Response.
- Genomic Aberrations
- Tuberculosis
- Mycobacterium tuberculosis
- Juvenile Idiopathic Arthritis
- Genome-Wide Association
- Oxidized LDL
- Immune Response
- Biological Therapy
- Inflammation
- Antiphospholipid Syndrome
- Autoantibodies
- Cytokines
- Systemic Lupus Erythematosus
- Rheumatoid Arthritis
- Atherosclerosis
- Genetic Variation
- Hemophagocytic Lymphohistiocytosis
- Ankylosing Spondylitis
- Spondyloarthritis
- Chronic Lymphocytic Leukemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Autoantibodies382 topics
- Antiphospholipid Syndrome221 topic
- Cytokines222 topics
- Inflammation222 topics
- Systemic Lupus Erythematosus221 topic
- Biological Therapy161 topic
- Rheumatoid Arthritis161 topic
- Immune Response102 topics
- Atherosclerosis61 topic
- Oxidized LDL61 topic
- Genetic Variation51 topic
- Genome-Wide Association51 topic
- Hemophagocytic Lymphohistiocytosis51 topic
- Juvenile Idiopathic Arthritis51 topic
- Ankylosing Spondylitis41 topic
- Mycobacterium tuberculosis41 topic
- Spondyloarthritis41 topic
- Tuberculosis41 topic
- Chronic Lymphocytic Leukemia31 topic
- Genomic Aberrations31 topic
Where does Eduardo M. Acevedo‐Vásquez work?
Eduardo M. Acevedo‐Vásquez's main affiliation in the publication record is Hospital Base Guillermo Almenara Irigoyen, Peru.
How many publications and citations does Eduardo M. Acevedo‐Vásquez have?
OpenAlex counts 50 works and 2,257 citations for Eduardo M. Acevedo‐Vásquez, an h-index of 18, ranking #1,016,726 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Eduardo M. Acevedo‐Vásquez. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.